Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Laryngeal cancer is a malignant tumor originating in the tissues of the larynx, primarily affecting middle-aged and elderly men, particularly those over 40. The disease is closely associated with factors such as smoking, alcohol consumption, and environmental irritants. Treatment options are diverse, including surgery, radiotherapy, chemotherapy, and emerging immune reconstruction cell therapy. If timely treatment is missed, the tumor may spread to nearby tissues or even distant organs, greatly increasing treatment difficulty and severely impacting patient survival and quality of life.
Immune reconstruction cell therapy enhances the patient’s own immune system to precisely recognize and eliminate laryngeal cancer cells, significantly boosting overall anticancer capacity. This therapy has minimal side effects and is suitable for combination with traditional treatments, improving patient quality of life.
1. Activate patient immune cells to enhance immune recognition
2. Precisely attack cancer cells, reducing damage to normal tissues
3. Combine with traditional therapies to improve overall outcomes
4. Improve immune microenvironment, reducing recurrence risk
In actual treatment, patients undergoing surgery, radiotherapy, or chemotherapy often face immune function impairment, increased infection risks, and slow recovery. To help patients better endure the treatment process and improve tolerance and survival quality, staged and scientifically designed immune reconstruction programs are required at different phases.
● Short-term plan: Rapidly enhance immunity through immune cell reinfusion, boosting the effects of anticancer treatment.
● Mid-term plan: Reduce side effects of traditional treatments, promote physical recovery, and ensure completion of standard treatment courses.
● Long-term plan: Improve overall immunity comprehensively through immune cell reconstruction, intestinal immunity rebuilding, elemental immune rebuilding, and immune nutrition reconstruction, thereby enhancing quality of life and prolonging survival.
1. Surgical Treatment
Surgical removal is the most common treatment for early-stage laryngeal cancer. Minimally invasive surgeries, such as laser laryngoscopy, can effectively remove tumors while preserving vocal function, reducing recovery time, and improving surgical safety.
2. Radiotherapy
Radiotherapy uses high-energy radiation to destroy cancer cells, suitable for patients where surgery is not possible or as adjuvant therapy after surgery. Modern intensity-modulated radiotherapy delivers radiation more precisely, minimizing damage to surrounding healthy tissues.
3. Chemotherapy
Chemotherapy is mainly used for advanced laryngeal cancer to inhibit tumor growth and spread. It is often combined with radiotherapy to improve efficacy, but careful management of chemotherapy-related side effects is necessary.
4. Minimally Invasive Treatment Methods
In addition to laser surgery, endoscopic minimally invasive resection techniques are increasingly used in laryngeal cancer treatment. These approaches cause less trauma, enable quicker recovery, and help preserve normal laryngeal functions, making them an optimal choice for early-stage patients.
5. Targeted Therapy
Targeted drugs interfere with specific molecular pathways in cancer cells to inhibit tumor growth. They are suitable for patients with certain gene abnormalities, offering precise efficacy with relatively fewer side effects.
6. Rehabilitation and Supportive Care
Rehabilitation includes speech therapy, nutritional support, and psychological counseling, helping patients regain vocal and swallowing functions. These measures are essential for improving quality of life and are an indispensable part of comprehensive treatment.
Laryngeal cancer treatment offers multiple approaches, with immune reconstruction cell therapy showing significant advantages. Experts at United Life International Medical Center emphasize that early diagnosis and personalized treatment plans are crucial for improving outcomes and prolonging survival. Patients are encouraged to actively participate in their treatment and manage their condition scientifically to achieve optimal recovery.
